Key to preventing runaway inflammation in patients with severe COVID-19

A treatment to prevent runaway inflammation in patients with severe COVID-19 is a step closer after a University of Queensland-led study into how immune cells respond to the virus.

Related Keywords

Kate Schroder ,Larisa Labzin ,Sarah Londrigan ,Emily Henderson ,Uq Institute For Molecular Bioscience ,Peter Doherty Institute For Infection ,Research Council ,National Health ,Professor Kate Schroder ,Molecular Bioscience ,Peter Doherty Institute ,Medical Research Council ,Chronic ,Inflammation ,Covid 19 ,Drugs ,Immune Response ,Immune System ,Immunity ,Research ,Cars ,Ars Cov 2 ,Virus ,